Showing results (11-20 of 321) with videos related to
Sort By:
Pageof 33
Neurology. Clinical Practice|February 19, 2026
Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021Daniel M Hartung, Nico Gabriel, Walid F Gellad, et al.The American Journal of Cardiology|July 19, 2020
Comparison of Oral Anticoagulant Use and Stroke Risk Among Older Adults Newly-Diagnosed Atrial Fibrillation Living in Urban-Versus-Rural AreasJingchuan Guo, Meiqi He, Jared W Magnani, et al.Journal of Managed Care & Specialty Pharmacy|April 28, 2021
A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?Alvaro San-Juan-Rodriguez, Walid F Gellad, William H Shrank, et al.Journal of Managed Care & Specialty Pharmacy|December 30, 2020
Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitorsAlvaro San-Juan-Rodriguez, Vincent M Piro, Chester B Good, et al.Journal of the National Medical Association|February 10, 2020
Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare DataUtibe R Essien, Jared W Magnani, Nemin Chen, et al.Health Affairs (Project Hope)|January 8, 2019
The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of DrugsInmaculada Hernandez, Chester B Good, David M Cutler, et al.JAMA Network Open|June 12, 2023
Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular DiseaseJing Luo, Robert Feldman, Katherine Callaway Kim, et al.Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillationJingchuan Serena Guo, Meiqi He, Nico Gabriel, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 13, 2024
COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial FibrillationLanting Yang, Shangbin Tang, Jingchuan Guo, et al.Journal of the American Pharmacists Association : Japha|January 31, 2022
The global impact of COVID-19 on drug purchases: A cross-sectional time series analysisKatie J Suda, Katherine Callaway Kim, Inmaculada Hernandez, et al.Pageof 33